Developer docs
API playgroundTry for free, no card

Search company profiles

Ovation Fertility

Full company profile

uuid0007d9k

Namestring
Ovation Fertility
Legal namestring
Ovation Fertility
Company typeenum
Private
Founded yearint
2015
Descriptiontext

Ovation Fertility is a private U.S. operator of in vitro fertilization (IVF) laboratories, founded in 2015 and headquartered in Nashville, Tennessee. Following its May 2023 combination with US Fertility, the company operates as part of a national fertility services platform with 28+ laboratories across 10+ states and 90+ affiliated clinic locations. Its core service lines are IVF laboratory services (embryology, andrology, cryopreservation), offsite lab directorship for partner fertility practices, long-term cryostorage via the Fertility Storage Solutions partnership, and preimplantation genetic testing through a Genomic Prediction LifeView PGT license. The company serves two primary customer segments: fertility practices and reproductive endocrinologists that contract Ovation for lab operations and technology access, and individual patients seeking IVF, ICSI, egg/sperm/embryo cryopreservation, and related reproductive services.

The underlying technology stack combines standard IVF laboratory infrastructure (HEPA-filtered cleanroom environments, electronic witnessing systems, advanced vitrification) with AI-assisted embryo selection capabilities sourced from third-party partners Presagen (Life Whisperer) and Alife Health. These computer-vision and predictive-analytics models rank embryos by combined genetics and viability scores and have been clinically studied at Ovation sites, including a 114-patient ASRM 2024 cohort showing a 69% ongoing pregnancy rate in AI-assisted cycles versus 64% in controls. Ovation also supports an epigenetic sperm quality test (SpermQT) studied in a 537-couple peer-reviewed cohort, and continuous biosensor-based hormone monitoring for ART treatment cycles.

Ovation generates revenue primarily through professional fees for IVF and related laboratory services performed for affiliated practices, managed-service lab directorship agreements, recurring subscription revenue from long-term cryostorage, and ancillary referral income from a CapexMD patient financing partnership. Pricing is not publicly disclosed and varies by patient protocol, geography, and contract terms with partner practices. The company sells through an enterprise field-sales motion targeting fertility practices and reproductive endocrinologists, supplemented by participation in ASRM and ESHRE industry conferences, clinical research publications, and a digital content presence. Ovation's CEO and Co-Founder is Nate Snyder; leadership additions since 2023 include a Chief Development Officer (Marty McGuirk) focused on M&A, a National Sales Director, and multiple board-certified HCLD laboratory directors.

Short descriptiontext

Ovation Fertility is a private U.S. operator of 28+ IVF laboratories across 10+ states, providing embryology, andrology, cryopreservation, and AI-assisted embryo selection services to affiliated fertility practices and patients as part of the US Fertility platform.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersLos Angeles, United States
HQ citystring
Los Angeles
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices7 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
IVF laboratory services, assisted reproductive technology, embryology and andrology, cryopreservation storage, preimplantation genetic testing
Industry3 codes
1Fertility, Reproductive Endocrinology & IVF Centers
CodeHLAFAJADPrimaryYes
2Reproductive Endocrinology & Infertility (IVF/Fertility)
CodeHLAKAJACPrimaryNo
3Prenatal, Newborn & Reproductive Diagnostics (NIPT, IVF/PGT, newborn screening)
CodeHLAAALAJPrimaryNo
NAICS code4 codes
  • Family Planning Centers621410
  • Family Planning Centers62141
  • Blood and Organ Banks621991
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code5 codes
  • Services-Specialty Outpatient Facilities, Nec8093
  • Services-Medical Laboratories8071
  • Services-Offices & Clinics Of Doctors Of Medicine8011
  • Services-Health Services8000
  • In Vitro & In Vivo Diagnostic Substances2835
Product category
Fertility Laboratory Services
Social media profiles2 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model4 records
1IVF Laboratory Services
TypeProfessional Services
Description

Core revenue stream from providing IVF laboratory services to affiliated fertility practices, including embryology, andrology, and genetic testing services performed in company-operated labs.

2Physician Partnership and Lab Directorship
TypeManaged Services
Description

Revenue generated through partnerships with fertility practices where Ovation provides lab directorship, operational management, and technical expertise for offsite laboratory facilities.

3Cryostorage Solutions
TypeSubscription Recurring
Description

Fees for long-term cryopreservation and storage of reproductive specimens including embryos, eggs, and sperm through Fertility Storage Solutions partnerships.

4IVF Financing Partnership
TypeAffiliate Referral
Description

Financial partnership with CapexMD providing financing options to patients, potentially generating referral or administrative fees.

Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Ovation Fertility operates a national network of IVF laboratories that provide advanced reproductive technology services — including embryology, andrology, preimplantation genetic testing, vitrification/cryopreservation, and AI-assisted embryo selection — to affiliated fertility practices under physician partnership and offsite lab directorship models, and to patients through cryostorage services.

Differentiator
Functional benefit
Problem solved
Product and service3 records
1IVF Laboratory Services
CategoryAssisted Reproductive Technology Services
Description

Centralized IVF laboratory services performed in Ovation-operated labs for affiliated fertility practices, including embryology, andrology, AI-assisted embryo selection, and preimplantation genetic testing.

2Offsite Lab Directorship
CategoryLaboratory Management Services
Description

Full laboratory directorship for partner fertility practices, in which Ovation Fertility operates IVF laboratories within partner practice facilities using company staff, technology, quality systems, and operational expertise.

3Cryostorage Solutions
CategoryCryopreservation Services
Description

Long-term vitrification, cryopreservation, and storage of embryos, eggs, and sperm through the Fertility Storage Solutions partnership, available to affiliated practices and to patients directly.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierCoreTypeTechnology or Integration
Description

Ovation Fertility has licensed the Genomic Prediction LifeView PGT Platform for preimplantation genetic testing services. This partnership provides access to comprehensive chromosomal screening and genetic risk assessment technology for embryos created through IVF treatments.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Collaboration on AI-assisted embryo selection research, developing and implementing artificial intelligence tools to improve embryo viability assessment and selection during IVF cycles.

Strategic tierCoreTypeTechnology or Integration
Description

Partnership to utilize Life Whisperer AI technology for embryo selection. Presagen's machine learning platform analyzes embryo images to help identify the most viable embryos for transfer.

Strategic tierMinorTypeOthers
Description

Financing partnership providing IVF financing options to patients. CapexMD offers patient financing solutions to help make fertility treatments more accessible through payment plans.

5Fertility Storage Solutions
Strategic tierCoreTypeTechnology or Integration
Description

Cryostorage partnership for long-term preservation of reproductive specimens including embryos, eggs, and sperm. Provides specialized storage infrastructure for the network's cryopreservation services.

Recent move9 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Market position
Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI capability7 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors2 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Ovation Fertility

Fertility Laboratory Servicesovationfertility.com

Ovation Fertility is a private U.S. operator of 28+ IVF laboratories across 10+ states, providing embryology, andrology, cryopreservation, and AI-assisted embryo selection services to affiliated fertility practices and patients as part of the US Fertility platform.

What Ovation Fertility does

Ovation Fertility is a private U.S. operator of in vitro fertilization (IVF) laboratories, founded in 2015 and headquartered in Nashville, Tennessee. Following its May 2023 combination with US Fertility, the company operates as part of a national fertility services platform with 28+ laboratories across 10+ states and 90+ affiliated clinic locations. Its core service lines are IVF laboratory services (embryology, andrology, cryopreservation), offsite lab directorship for partner fertility practices, long-term cryostorage via the Fertility Storage Solutions partnership, and preimplantation genetic testing through a Genomic Prediction LifeView PGT license. The company serves two primary customer segments: fertility practices and reproductive endocrinologists that contract Ovation for lab operations and technology access, and individual patients seeking IVF, ICSI, egg/sperm/embryo cryopreservation, and related reproductive services.

The underlying technology stack combines standard IVF laboratory infrastructure (HEPA-filtered cleanroom environments, electronic witnessing systems, advanced vitrification) with AI-assisted embryo selection capabilities sourced from third-party partners Presagen (Life Whisperer) and Alife Health. These computer-vision and predictive-analytics models rank embryos by combined genetics and viability scores and have been clinically studied at Ovation sites, including a 114-patient ASRM 2024 cohort showing a 69% ongoing pregnancy rate in AI-assisted cycles versus 64% in controls. Ovation also supports an epigenetic sperm quality test (SpermQT) studied in a 537-couple peer-reviewed cohort, and continuous biosensor-based hormone monitoring for ART treatment cycles.

Ovation generates revenue primarily through professional fees for IVF and related laboratory services performed for affiliated practices, managed-service lab directorship agreements, recurring subscription revenue from long-term cryostorage, and ancillary referral income from a CapexMD patient financing partnership. Pricing is not publicly disclosed and varies by patient protocol, geography, and contract terms with partner practices. The company sells through an enterprise field-sales motion targeting fertility practices and reproductive endocrinologists, supplemented by participation in ASRM and ESHRE industry conferences, clinical research publications, and a digital content presence. Ovation's CEO and Co-Founder is Nate Snyder; leadership additions since 2023 include a Chief Development Officer (Marty McGuirk) focused on M&A, a National Sales Director, and multiple board-certified HCLD laboratory directors.

Ovation Fertility firmographics

Firmographics
Name
Ovation Fertility
Legal name
Ovation Fertility
Website
https://www.ovationfertility.com/
Company type
Private
Founded year
2015
Operating status
Operating
Headcount range
101–250 employees
Short description
Ovation Fertility is a private U.S. operator of 28+ IVF laboratories across 10+ states, providing embryology, andrology, cryopreservation, and AI-assisted embryo selection services to affiliated fertility practices and patients as part of the US Fertility platform.
Ownership category
akta.pro rank

Ovation Fertility industry classification

Industry
Product category
Fertility Laboratory Services
NAICS
Family Planning Centers (621410), Family Planning Centers (62141), Blood and Organ Banks (621991), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
Services-Specialty Outpatient Facilities, Nec (8093), Services-Medical Laboratories (8071), Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Health Services (8000), In Vitro & In Vivo Diagnostic Substances (2835)
akta.pro primary industry
Fertility, Reproductive Endocrinology & IVF Centers (HLAFAJAD)
akta.pro secondary industries
Reproductive Endocrinology & Infertility (IVF/Fertility) (HLAKAJAC), Prenatal, Newborn & Reproductive Diagnostics (NIPT, IVF/PGT, newborn screening) (HLAAALAJ)

Keywords

  • IVF laboratory services
  • Assisted reproductive technology
  • Embryology and andrology
  • Cryopreservation storage
  • Preimplantation genetic testing

Where Ovation Fertility is headquartered

Location

Headquarters

HQ city
Los Angeles
HQ country
United States
HQ region
North America

Offices7 records

Markets served

Ovation Fertility business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

  1. IVF Laboratory Services: Core revenue stream from providing IVF laboratory services to affiliated fertility practices, including embryology, andrology, and genetic testing services performed in company-operated labs.
  2. Physician Partnership and Lab Directorship: Revenue generated through partnerships with fertility practices where Ovation provides lab directorship, operational management, and technical expertise for offsite laboratory facilities.
  3. Cryostorage Solutions: Fees for long-term cryopreservation and storage of reproductive specimens including embryos, eggs, and sperm through Fertility Storage Solutions partnerships.
  4. IVF Financing Partnership: Financial partnership with CapexMD providing financing options to patients, potentially generating referral or administrative fees.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Ovation Fertility product offering

Product offering

Core offering

Ovation Fertility operates a national network of IVF laboratories that provide advanced reproductive technology services — including embryology, andrology, preimplantation genetic testing, vitrification/cryopreservation, and AI-assisted embryo selection — to affiliated fertility practices under physician partnership and offsite lab directorship models, and to patients through cryostorage services.

Differentiator

Problem solved

Functional benefit

Products and services

  • IVF Laboratory Services Centralized IVF laboratory services performed in Ovation-operated labs for affiliated fertility practices, including embryology, andrology, AI-assisted embryo selection, and preimplantation genetic testing.
  • Offsite Lab Directorship Full laboratory directorship for partner fertility practices, in which Ovation Fertility operates IVF laboratories within partner practice facilities using company staff, technology, quality systems, and operational expertise.
  • Cryostorage Solutions Long-term vitrification, cryopreservation, and storage of embryos, eggs, and sperm through the Fertility Storage Solutions partnership, available to affiliated practices and to patients directly.

Companies that use Ovation Fertility

Customer profile

Named customers2 records

Segments2 records

Ideal customer profiles2 records

Ovation Fertility technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability7 records

Feature5 records

Ovation Fertility partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered core and minor.

  • Genomic PredictioncoreTechnology or IntegrationOvation Fertility has licensed the Genomic Prediction LifeView PGT Platform for preimplantation genetic testing services. This partnership provides access to comprehensive chromosomal screening and genetic risk assessment technology for embryos created through IVF treatments.
  • Alife HealthcoreStrategic or Co-development PartnerCollaboration on AI-assisted embryo selection research, developing and implementing artificial intelligence tools to improve embryo viability assessment and selection during IVF cycles.
  • PresagencoreTechnology or IntegrationPartnership to utilize Life Whisperer AI technology for embryo selection. Presagen's machine learning platform analyzes embryo images to help identify the most viable embryos for transfer.
  • CapexMDminorOthersFinancing partnership providing IVF financing options to patients. CapexMD offers patient financing solutions to help make fertility treatments more accessible through payment plans.
  • Fertility Storage SolutionscoreTechnology or IntegrationCryostorage partnership for long-term preservation of reproductive specimens including embryos, eggs, and sperm. Provides specialized storage infrastructure for the network's cryopreservation services.

Scale indicators4 records

Recent moves9 records

Expansion highlights5 records

Ovation Fertility competitors and assessment

Company assessment

Market position

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Ovation Fertility social profiles

Digital presence

Ovation Fertility financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Ovation Fertility leadership team

Management profile

Number of profiles

Profiles7 records

Ovation Fertility funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Ovation Fertility M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ovation Fertility

What does Ovation Fertility do?

Ovation Fertility operates a national network of IVF laboratories that provide advanced reproductive technology services — including embryology, andrology, preimplantation genetic testing, vitrification/cryopreservation, and AI-assisted embryo selection — to affiliated fertility practices under physician partnership and offsite lab directorship models, and to patients through cryostorage services.

Is Ovation Fertility a public or private company?

Ovation Fertility is a private company. It is classified as corporate owned and is currently operating.

When was Ovation Fertility founded?

Ovation Fertility was founded in 2015. It employs 101 to 250 people.

Where is Ovation Fertility based?

Ovation Fertility is headquartered in Los Angeles, United States, in the North America region.

How does Ovation Fertility make money?

Four revenue lines are on record. IVF Laboratory Services are the primary driver. The others are physician Partnership and Lab Directorship, cryostorage Solutions and IVF Financing Partnership.

Does Ovation Fertility have an API?

No public API is recorded for Ovation Fertility.

What industry is Ovation Fertility in?

Ovation Fertility's product category is Fertility Laboratory Services. Its primary akta.pro industry code is HLAFAJAD, Fertility, Reproductive Endocrinology & IVF Centers, with a secondary code of HLAKAJAC, Reproductive Endocrinology & Infertility (IVF/Fertility). Its NAICS code is 621410 and its SIC code is 8093.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
EIN PresswireTexas Fertility Center Announces Reopening of Austin Fertility Surgery Center in San AntonioAustin Fertility Surgery Center in San Antonio will reopen April 27, 2026, after extensive upgrades. The state-of-the-art facility supports IVF procedures including oocyte retrievals and embryo transfers, with services from Texas Fertility Center and Ovation Fertility.EIN PresswireOvation Fertility presents IVF insights at 2025 ASRM Scientific Congress & ExpoOvation Fertility's research team will present two studies at the American Society for Reproductive Medicine 2025 Scientific Congress & Expo in San Antonio, Texas, from October 25-29, 2025. The studies focus on evaluating artificial intelligence for embryo selection during IVF and comparing miscarriage rates following single untested versus euploid frozen embryo transfer. The presentations underscore Ovation's commitment to advancing reproductive medicine and improving patient outcomes through evidence-based research.YahooFertility Test Market Report 2025-2033, with Profiles of Quest Diagnostics, Mayo Clinic Laboratories, Ovation Fertility, Illume Fertility, Proov, BioMerieux, Labcorp, CCRM Fertility, and Maven ClinicThe global fertility test market is projected to grow from $7.92 billion in 2025 to $14.74 billion by 2033, an 8.08% CAGR. Growth is driven by rising infertility rates, lifestyle changes, and greater acceptance of testing. The report also segments the market by test type, application, sample type, and region.UsfertilityAbout US Fertility: Innovation in Reproductive Medicine — US FertilityUS Fertility and Ovation Fertility operate as a unified partnership to provide reproductive medicine services, leveraging combined expertise across more than 100 clinic locations and 32 IVF laboratories. Together, these entities have facilitated over 225,000 births through assisted reproductive technology while supporting over 200 physicians with business and digital solutions.OvationfertilityNew AI-assisted embryo selection research shows promise for enhancing fertility treatment outcomes — Ovation FertilityOvation Fertility and Alife Health presented interim research at the 80th ASRM Scientific Congress exploring AI-assisted embryo selection during IVF procedures, using an AI system that non-invasively analyzes blastocyst-stage embryo images to predict pregnancy likelihood. The study of 114 patients found a 69% ongoing pregnancy rate in the AI-assisted group versus 64% in the control group, though the difference was not statistically significant, with no safety concerns identified. Final results are expected later this year, potentially advancing the integration of AI into reproductive medicine.GlobeNewswireOvation Fertility Welcomes Pradeep Warikoo, PhD, HCLD, ELD, CC (ABB), as Cincinnati Lab DirectorPradeep Warikoo, PhD, joined Ovation Fertility as Cincinnati lab director on February 1, 2024, after 25 years at Bethesda Fertility Center. He will oversee IVF and andrology labs and lead a new standalone andrology lab that opened February 15. He brings over three decades of IVF laboratory experience.OvationfertilityContinuous in-situ monitoring of female hormone levels as a tool to improve the efficacy of assisted reproductive technology (ART) and in-vitro fertilization (IVF) treatment — Ovation FertilityResearchers from Impli Health and Ovation Fertility presented a study demonstrating the feasibility of an implantable biosensor for continuous, real-time monitoring of female hormone levels during assisted reproductive technology cycles. The device successfully detected Progesterone and Beta-estradiol within clinically relevant ranges in vitro, offering a less invasive alternative to frequent blood draws. Future validation through animal trials is planned to optimize the sensor for potential clinical use.GlobeNewswireOvation Fertility Licenses Genomic Prediction’s LifeView PGT PlatformOvation Fertility licensed Genomic Prediction's LifeView PGT platform to offer five preimplantation genetic testing options. The partnership expands PGT capabilities, including PGT-A, PGT-A+, PGT-SR, PGT-M, and PGT-P, with studies showing improved clinical outcomes. The company aims to provide better outcomes for IVF patients.PR NewswireOvation Fertility Licenses Genomic Prediction's LifeView PGT to Provide Patients with the Most Advanced Testing AvailableOvation Fertility, a leading US IVF service provider, has partnered with Genomic Prediction to license the LifeView PGT Platform for preimplantation genetic testing. Clinical studies comparing LifeView PGT to conventional NGS methods demonstrated improved outcomes including higher pregnancy rates and lower miscarriage rates for IVF patients. The platform offers advanced capabilities including Embryo Health Scores for polygenic conditions, with clinical trial data showing over half of informed IVF patients elect to use this feature.GlobeNewswireStephanie Rampello Joins Ovation to Become Director of Fertility Storage SolutionsStephanie Rampello has been appointed director of Fertility Storage Solutions at Ovation Fertility, overseeing frozen reproductive materials. She previously co-founded WellNested and served as director of specialty care at SonderMind. She plans to improve operational efficiency and protect patients' family-building materials.